Crinetics Pharmaceuticals is committed to raising awareness of endocrine diseases and supporting research projects and awareness initiatives for related symptoms and treatments. Accordingly, we provide medical education grants and research funding to qualified researchers for investigator-initiated studies (IIS).

Medical Education Grants

Healthcare organizations and professionals can apply for a medical education grant to support bonafide educational programs and activities related to disease awareness and improvement of patient care. To be eligible, applicants must meet the following requirements:

  • Demonstrate that the proposed medical education provided through the grant will promote improved delivery of healthcare
  • Be an independent, accredited medical educator that conforms to Food and Drug Administration (FDA) and Accreditation Council for Continuing Medical Education (ACCME) standards
  • The proposed medical education is not satisfied under existing programs
  • Must complete an agreement with Crinetics

Crinetics invites accredited educational providers to submit applications for independent, certified medical education grants subject to the terms described below. This Request for Proposals (RFP) provides public notice of the availability of funds in a general topic area for activities for which recognized scientific or educational needs exist and funding is available.

Title: Acromegaly Management and Considerations of Clinical Guidelines and Emerging Therapies

Application Due Date: February 7, 2025; 5:00 PM PT

Apply

For any questions, please contact [email protected].

Investigator Initiated Studies (IIS)

Independent endocrine disease research may also qualify for funding. You may qualify if you meet the following requirements:

  • Research demonstrates familiarity with Crinetics’ investigational treatments
    • The following Crinetics investigational drug candidates are currently in clinical development:
      • Paltusotine, an oral nonpeptide selective SST2 agonist for the treatment of Acromegaly and Carcinoid syndrome associated with neuroendocrine tumors
      • CRN04894, an ACTH (MC2R) antagonist for the treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH Dependent Cushing’s Syndrome (ADCS)
  • Crinetics is happy to consider investigator-initiated research proposals relevant to these disease states, in the following areas:
    • Epidemiology (including real world evidence and burden of disease research)
    • Stability of disease control achieved by current treatments and associated impact on patients, health care providers and healthcare systems
    • Evaluation of patient reported outcome tools
    • Research related to other diseases that may be appropriate for treatment with an ACTH antagonist can be considered on a case-by-case basis.
  • Deliverables are tangible and follow scientific methods
  • Crinetics support of the research must be clearly acknowledged and disclosed in all publication of study data and results
  • The IIS applicant is solely responsible and exercises full control of the execution and planning of the study
  • Must complete an agreement with Crinetics
Apply

For any questions, please contact [email protected].

Application Requirements

By submitting an application you are not guaranteed the approval of the funding request. Crinetics Pharmaceuticals follows a thorough review process and will approve or deny requests at its sole discretion.

In addition to a completed application, you will need to provide the following with your submission:

Medical Education Grants

  • Letter of request, signed and dated on your organization’s letterhead, that includes the following:
    • Educational objectives
    • Needs assessment
    • Agenda
    • Full program budget
    • Program description that includes how you will use the grant
    • Anticipated number of participants
    • Name of accrediting body and provider, including type and amount of credits (must be accredited)
  • W-9 form (US) or W-8 (non-US)
  • IRS tax determination letter (if applicable)
  • Before the start of a medical education grant, an agreement must be complete and fully executed.

Investigator Initiated Studies (IIS)

  • Letter of request, signed and dated on your organization’s letterhead, that includes the following:
    • Scientific rationale
    • Scope and objective of the study
    • Methodology, including patient selection criteria, study design, sample size justification, dosing (if applicable), and a data analysis plan
    • Data reporting plan
    • Nature and amount of support requested
    • Projected timeline
    • Curriculum Vitae for all investigators
  • W-9 form (US) or W-8 (non-US)
  • IRS tax determination letter (if applicable)
  • If funded, a final study report (publication can be in lieu of study report) must be provided upon completion of study, and Crinetics’ support must be acknowledged in all publications/presentations of study data
  • Funding will not be provided for:
    • Individuals
    • Fellowships
    • Overhead and general operating expenses
    • Entertainment, including meals
    • Awards
    • Travel
  • Before the start of an IIS, an agreement must be complete and fully executed.